TEVA PHARMACEUTICAL INDUSTRIES LIMITED Common Stock Dividends Paid
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Common Stock Dividends Paid of $12.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsCommonStock · last filed 2020-02-21
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for the quarter ending 2018-03-31 was $12.00M, a 96.53% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for fiscal 2018 was $12.00M, a 98.67% decline from fiscal 2017.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for fiscal 2017 was $901.00M, a 30.85% decline from fiscal 2016.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for fiscal 2016 was $1.30B, a 12.81% increase from fiscal 2015.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments of ordinary dividends, common stock for fiscal 2015 was $1.16B.
| Period end | Payments of Ordinary Dividends, Common Stock 3 month | Payments of Ordinary Dividends, Common Stock 6 month | Payments of Ordinary Dividends, Common Stock 9 month | Payments of Ordinary Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-02-21 | $0.00 derived: sum of 3 quarters · filed 2020-02-21 | $12.00M 10-K · filed 2020-02-21 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $12.00M 10-Q · filed 2018-11-01 | $99.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $12.00M 10-Q · filed 2018-08-02 | $99.00M derived: sum of 3 quarters · filed 2020-02-21 | $222.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $12.00M 10-Q · filed 2018-05-03 | $99.00M derived: sum of 2 quarters · filed 2020-02-21 | $222.00M derived: sum of 3 quarters · filed 2020-02-21 | $567.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $210.00M derived: sum of 2 quarters · filed 2020-02-21 | $555.00M derived: sum of 3 quarters · filed 2020-02-21 | $901.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $123.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $468.00M derived: sum of 2 quarters · filed 2018-11-01 | $814.00M 10-Q · filed 2018-11-01 | $1.16B derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $345.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $691.00M 10-Q · filed 2018-08-02 | $1.04B derived: sum of 3 quarters · filed 2018-08-02 | $1.38B derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $346.00M 10-Q · filed 2018-05-03 | $692.00M derived: sum of 2 quarters · filed 2018-05-03 | $1.03B derived: sum of 3 quarters · filed 2018-05-03 | $1.34B derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $346.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $686.00M derived: sum of 2 quarters · filed 2018-02-12 | $996.00M derived: sum of 3 quarters · filed 2018-02-12 | $1.30B 10-K · filed 2019-02-19 |
| 2016-09-30 | $340.00M derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | $650.00M derived: sum of 2 quarters · filed 2017-11-02 | $957.00M 6-K · filed 2017-11-02 | $1.25B derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-06-30 | $310.00M derived: 6-K 6 month − 6-K 3 month · filed 2017-08-03 | $617.00M 6-K · filed 2017-08-03 | $907.00M derived: sum of 3 quarters · filed 2018-02-12 | $1.19B derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-03-31 | $307.00M 6-K · filed 2017-05-11 | $597.00M derived: sum of 2 quarters · filed 2018-02-12 | $884.00M derived: sum of 3 quarters · filed 2018-02-12 | $1.17B derived: sum of 4 quarters · filed 2018-02-12 |
| 2015-12-31 | $290.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $577.00M derived: sum of 2 quarters · filed 2018-02-12 | $865.00M derived: sum of 3 quarters · filed 2018-02-12 | $1.16B 10-K · filed 2018-02-12 |
| 2015-09-30 | $287.00M derived: 6-K 9 month − 6-K 6 month · filed 2016-11-15 | $575.00M derived: sum of 2 quarters · filed 2016-11-15 | $865.00M 6-K · filed 2016-11-15 | $1.14B derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | $288.00M derived: 6-K 6 month − 6-K 3 month · filed 2016-08-04 | $578.00M 6-K · filed 2016-08-04 | $850.00M derived: sum of 3 quarters · filed 2017-02-15 | $1.14B derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | $290.00M 6-K · filed 2016-05-09 | $562.00M derived: sum of 2 quarters · filed 2017-02-15 | $856.00M derived: sum of 3 quarters · filed 2017-02-15 | $1.16B derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | $272.00M derived: 20-F 12 month − 6-K 9 month · filed 2017-02-15 | $566.00M derived: sum of 2 quarters · filed 2017-02-15 | $865.00M derived: sum of 3 quarters · filed 2017-02-15 | $1.16B 20-F · filed 2017-02-15 |
| 2014-09-30 | $294.00M derived: 6-K 9 month − 6-K 6 month · filed 2015-10-29 | $593.00M derived: sum of 2 quarters · filed 2015-10-29 | $884.00M 6-K · filed 2015-10-29 | $1.16B derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $299.00M derived: 6-K 6 month − 6-K 3 month · filed 2015-07-30 | $590.00M 6-K · filed 2015-07-30 | $866.00M derived: sum of 3 quarters · filed 2016-02-11 | $1.13B derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | $291.00M 6-K · filed 2015-04-30 | $567.00M derived: sum of 2 quarters · filed 2016-02-11 | $831.00M derived: sum of 3 quarters · filed 2016-02-11 | $1.10B derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | $276.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $540.00M derived: sum of 2 quarters · filed 2016-02-11 | $808.00M derived: sum of 3 quarters · filed 2016-02-11 | $1.09B 20-F · filed 2016-02-11 |
| 2013-09-30 | $264.00M derived: 6-K 9 month − 6-K 6 month · filed 2014-10-30 | $532.00M derived: sum of 2 quarters · filed 2014-10-30 | $813.00M 6-K · filed 2014-10-30 | $1.03B derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-06-30 | $268.00M derived: 6-K 6 month − 6-K 3 month · filed 2014-07-31 | $549.00M 6-K · filed 2014-07-31 | $763.00M derived: sum of 3 quarters · filed 2015-02-09 | $1.00B derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-03-31 | $281.00M 6-K · filed 2014-05-02 | $495.00M derived: sum of 2 quarters · filed 2015-02-09 | $732.00M derived: sum of 3 quarters · filed 2015-02-09 | $962.00M derived: sum of 4 quarters · filed 2015-02-09 |
| 2012-12-31 | $214.00M derived: 20-F 12 month − 6-K 9 month · filed 2015-02-09 | $451.00M derived: sum of 2 quarters · filed 2015-02-09 | $681.00M derived: sum of 3 quarters · filed 2015-02-09 | $855.00M 20-F · filed 2015-02-09 |
| 2012-09-30 | $237.00M derived: 6-K 9 month − 6-K 6 month · filed 2013-10-31 | $467.00M derived: sum of 2 quarters · filed 2013-10-31 | $641.00M 6-K · filed 2013-10-31 | $831.00M derived: sum of 4 quarters · filed 2014-02-10 |
| 2012-06-30 | $230.00M derived: 6-K 6 month − 6-K 3 month · filed 2013-08-01 | $404.00M 6-K · filed 2013-08-01 | $594.00M derived: sum of 3 quarters · filed 2014-02-10 | $798.00M derived: sum of 4 quarters · filed 2014-02-10 |
| 2012-03-31 | $174.00M 6-K · filed 2013-05-02 | $364.00M derived: sum of 2 quarters · filed 2014-02-10 | $568.00M derived: sum of 3 quarters · filed 2014-02-10 | $771.00M derived: sum of 4 quarters · filed 2014-02-10 |
| 2011-12-31 | $190.00M derived: 20-F 12 month − 6-K 9 month · filed 2014-02-10 | $394.00M derived: sum of 2 quarters · filed 2014-02-10 | $597.00M derived: sum of 3 quarters · filed 2014-02-10 | $800.00M 20-F · filed 2014-02-10 |
| 2011-09-30 | $204.00M derived: 6-K 9 month − 6-K 6 month · filed 2012-11-01 | $407.00M derived: sum of 2 quarters · filed 2012-11-01 | $610.00M 6-K · filed 2012-11-01 | $782.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2011-06-30 | $203.00M derived: 6-K 6 month − 6-K 3 month · filed 2012-08-02 | $406.00M 6-K · filed 2012-08-02 | $578.00M derived: sum of 3 quarters · filed 2013-02-12 | $745.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2011-03-31 | $203.00M 6-K · filed 2012-05-09 | $375.00M derived: sum of 2 quarters · filed 2013-02-12 | $542.00M derived: sum of 3 quarters · filed 2013-02-12 | $706.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2010-12-31 | $172.00M derived: 20-F 12 month − 6-K 9 month · filed 2013-02-12 | $339.00M derived: sum of 2 quarters · filed 2013-02-12 | $503.00M derived: sum of 3 quarters · filed 2013-02-12 | $668.00M 20-F · filed 2013-02-12 |
| 2010-09-30 | $167.00M derived: 6-K 9 month − 6-K 6 month · filed 2011-11-02 | $331.00M derived: sum of 2 quarters · filed 2011-11-02 | $496.00M 6-K · filed 2011-11-02 | |
| 2010-06-30 | $164.00M derived: 6-K 6 month − 6-K 3 month · filed 2011-07-28 | $329.00M 6-K · filed 2011-07-28 | ||
| 2010-03-31 | $165.00M 6-K · filed 2011-05-11 | |||
| 2009-12-31 | $529.00M 20-F · filed 2012-02-17 | |||
| 2008-12-31 | $387.00M 20-F · filed 2011-02-15 |